International Mesenchymal Stem Cell Trial Results Show No Benefits against Inflammation in Active MSNovember 4, 2021Results have been published from a phase 2 clinical trial conducted at 15 sites in 9 countries, testing the ability ofsenchymal..#Multiple Sclerosis·disorders.solutions·Dec 5, 2021International Mesenchymal Stem Cell Trial Results Show No Benefits against Inflammation in Active MS